van Keulen Anne-Marleen, Buettner Stefan, Besselink Marc G, Busch Olivier R, van Gulik Thomas M, Ijzermans Jan N M, de Jonge Jeroen, Polak Wojciech G, Swijnenburg Rutger-Jan, Groot Koerkamp Bas, Erdmann Joris I, Olthof Pim B
Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Surgery, Reinier de Graaf Gasthuis, Delft, the Netherlands.
Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
HPB (Oxford). 2021 Oct;23(10):1607-1614. doi: 10.1016/j.hpb.2021.03.016. Epub 2021 Apr 20.
Surgery for perihilar cholangiocarcinoma (pCCA) is associated with high morbidity and mortality rates. The impact of surgery for pCCA may affect patients after discharge. The aim of this study was to investigate all morbidity and mortality during the first year after surgery for pCCA.
All consecutive liver resections for suspected pCCA between 2000 and 2019 at two tertiary referral centers were included. All morbidity and mortality until one year after surgery was collected retrospectively, including readmissions and reinterventions. All recurrences within the first year were scored to calculate disease-free survival.
In 250 patients, the major morbidity rate was 61% (152/250), in-hospital mortality was 15% (37/250) and 90-day mortality was 16% (40/250). In the 213 discharged patients, 98 patients (46%) suffered 260 surgical complications. These complications required 185 readmissions in 92 patients (43%) and 400 reinterventions in 110 patients (52%), including 330 radiological (83%), 61 endoscopic (15%) and 9 surgical reinterventions (2%). One-year overall survival was 77% and one-year disease-free survival was 70%. Out of the 20 patients who died within the first year after discharge, 15 died of recurrent disease and 3 due to surgery related complications and 2 of unknown causes.
Readmissions, reinterventions and complications are frequent throughout the first year after surgery for pCCA in tertiary referral hospitals. These adverse events warrants treatment of these complex patients in high expertise centers offering intensive perioperative care and close follow-up of patients after discharge.
肝门部胆管癌(pCCA)手术的发病率和死亡率较高。pCCA手术的影响可能在患者出院后显现。本研究旨在调查pCCA手术后第一年的所有发病率和死亡率。
纳入2000年至2019年间在两家三级转诊中心连续进行的疑似pCCA肝切除术患者。回顾性收集术后一年以内的所有发病率和死亡率,包括再次入院和再次干预情况。对第一年的所有复发情况进行评分以计算无病生存期。
250例患者中,主要发病率为61%(152/250),住院死亡率为15%(37/250),90天死亡率为16%(40/250)。在213例出院患者中,98例(46%)出现260次手术并发症。这些并发症导致92例患者(43%)再次入院185次,110例患者(52%)再次干预400次,其中包括330次放射介入(83%)、61次内镜介入(15%)和9次手术再次干预(2%)。一年总生存率为77%,一年无病生存率为70%。在出院后第一年内死亡的20例患者中,15例死于疾病复发,3例死于手术相关并发症,2例死因不明。
在三级转诊医院,pCCA手术后的第一年,再次入院、再次干预和并发症很常见。这些不良事件表明,需要在具备专业围手术期护理和出院后密切随访能力的高专业水平中心对这些复杂患者进行治疗。